Home  >  Products  >  AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2 ) Blocking Peptide (100ug)
AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2 ) Blocking Peptide (100ug)

AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2 ) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-AGPAT2 antibody (Catalogue #: ARP44637_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP44637
Size: 100 ug
Weight: 27kDa
Gene: 10555
Format: Lyophilized powder
Target: AGPAT2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance.This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Alternative names: 1-AGPAT2; BSCL; BSCL1; LPAAB; LPAAT-beta
See Full Product Listings >